Cleared Special

K220109 - DIAMONDBACK 360 Peripheral Orbital Atherectomy System, DIAMONDBACK 360 Peripheral Orbital Atherectomy System, Exchangeable Series, Stealth 360 Peripheral Orbital Atherectomy System (FDA 510(k) Clearance)

Mar 2022
Decision
47d
Days
Class 2
Risk

K220109 is an FDA 510(k) clearance for the DIAMONDBACK 360 Peripheral Orbital Atherectomy System, DIAMONDBACK 360 Peripheral Orbital Atherectomy System, Exchangeable Series, Stealth 360 Peripheral Orbital Atherectomy System. This device is classified as a Catheter, Peripheral, Atherectomy (Class II - Special Controls, product code MCW).

Submitted by Cardiovascular Systems, Inc. (St.Paul, US). The FDA issued a Cleared decision on March 1, 2022, 47 days after receiving the submission on January 13, 2022.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.4875.

Submission Details

510(k) Number K220109 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 13, 2022
Decision Date March 01, 2022
Days to Decision 47 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code MCW — Catheter, Peripheral, Atherectomy
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.4875

Similar Devices — MCW Catheter, Peripheral, Atherectomy

All 7
Rotarex Atherectomy System
K242757 · Bard Peripheral Vascular, Inc. · Jan 2025
Pantheris LV Atherectomy Catheter
K230005 · Avinger, Inc. · Jun 2023
ROTAPRO Rotational Atherectomy System
K220962 · Boston Scientific Corporation · Sep 2022
Pantheris System
K212047 · Avinger, Inc. · Nov 2021
Diamonback 360 Peripheral Orbital Atherectomy System, Diamondback 360 Stealth Orbital Atherectomy system
K210586 · Cardiovascular Systems, Inc. · Sep 2021
Rotarex Atherectomy System
K211738 · C.R. Bard, Inc. · Sep 2021